Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema.

Teufel,D.P., Bennett,G., Harrison,H., van,R.K., Pavan,S., Stace,C., Le,F.F., Van,B.T., Vermassen,E., Barbeaux,P., Hu,T.T., Feyen,J.H.M., and Vanhove,M. 2018. Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular Edema. J. Med. Chem. 61, 2823-2836.